KBP_042



NAME OF DRUG : KBP_042

ALSO KNOWN AS : KBP_042

LABORATORY : NORDICBIOSCIENCE

STATUS AND ADVANCEMENT

Type of drug : (DACRA)

Clinical trials advancement : Analysing Results Phase 1

Estimated time to market : 123 months.

LABORATORY ABSTRACT ON THE DRUG

NOT PROVIDED

RECENT NEWS ON KBP_042

SOME PUBLICATIONS RELATED WITH KBP_042

SOME NASHBIOTECHS POINTS OF VIEW RELATED WITH KBP_042


WWW.NASHBIOTECHS.COM  -  Copyright G DIVRY 2015-2016  - Contact and TERMS OF USE